Archive: April, 2022

28

Apr2022

Aadi Bioscience to Announce First Quarter 2022 Financial Results on May 12, 2022

0  
LOS ANGELES, April 28, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (Nasdaq: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announced that it will report results for the first quarter 2022 before market open on Thursday, May ... Read More
April 28, 2022

18

Apr2022

Aadi Bioscience to Participate at the Jefferies “Biotech on the Bay” Summit

0  
LOS ANGELES, April 18, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”) (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announced that Founder, Chief Executive Officer and President, Neil Desai, Ph.D., and senior members of Aadi's ... Read More
April 18, 2022